Myriad Genetics: Mark Pollack
Myriad Genetics has named Mark Pollack as chief medical officer of Myriad Neuroscience. Pollack will start in this new role on Jan. 15, 2020, and will report to Mark Verratti, president of the neuroscience division. In this position, Pollack will be in charge of efforts to integrate the GeneSight pharmacogenetic test into clinical practice. Pollack is a psychiatrist with three decades of experience in clinical psychiatry and neuroscience. He served as professor and chair of the psychiatry department at Rush University Medical Center in Chicaco, and before that he was a psychiatry professor at Harvard Medical School and directed the Center of Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital.